HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Saraceni Selected Research

VEXAS syndrome

2/2024Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Saraceni Research Topics

Disease

10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 09/2014
6Leukemia
10/2023 - 07/2017
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 10/2020
3Multiple Myeloma
10/2022 - 09/2017
3Lymphoma (Lymphomas)
01/2018 - 09/2017
1VEXAS syndrome
02/2024
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2023
1Central Pontine Myelinolysis
12/2021
1Lung Injury
02/2021
1Bronchiolitis Obliterans Syndrome
02/2021
1COVID-19
02/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
02/2021
1Residual Neoplasm
10/2020
1Neoplasms (Cancer)
01/2018
1Cytopenia
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2017
1Abscess
12/2014

Drug/Important Bio-Agent (IBA)

4fludarabineIBA
10/2023 - 01/2018
4Busulfan (Busulfex)FDA Link
10/2023 - 01/2018
4Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
10/2023 - 01/2018
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023 - 10/2018
2treosulfanIBA
10/2023 - 01/2019
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 01/2018
2plerixaforFDA Link
01/2018 - 09/2017
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018 - 09/2014
1Inotuzumab OzogamicinIBA
12/2023
1Bortezomib (Velcade)FDA Link
10/2022
1Lenalidomide (CC 5013)FDA Link
10/2022
1Thalidomide (Thalomid)FDA Link
10/2022
1ruxolitinibIBA
02/2021
1CytokinesIBA
02/2021
1Chimeric Antigen ReceptorsIBA
10/2020
1Tyrosine Kinase InhibitorsIBA
10/2020
1Monoclonal AntibodiesIBA
10/2020
1AntigensIBA
10/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2020
1Bispecific AntibodiesIBA
10/2020
1Melphalan (Alkeran)FDA LinkGeneric
01/2018
1Etoposide (VP 16)FDA LinkGeneric
01/2018
1Carmustine (FIVB)FDA Link
01/2018
1Filgrastim (Neupogen)FDA Link
09/2017
1Biosimilar PharmaceuticalsIBA
09/2017
1Gemtuzumab (Mylotarg)FDA Link
09/2014

Therapy/Procedure

7Stem Cell Transplantation
10/2022 - 09/2014
5Hematopoietic Stem Cell Transplantation
12/2023 - 01/2018
5Therapeutics
10/2022 - 09/2014
2Transplantation
01/2021 - 01/2019
2Hematopoietic Stem Cell Mobilization
01/2021 - 09/2017
1Cell Transplantation
02/2024
1Drug Therapy (Chemotherapy)
01/2018
1Laparotomy
12/2014